Endocyte shares plunge 60 percent after drug trial is stopped
Endocyte Inc.’s stock fell more than 60 percent in early trading Friday after the drug it’s developing with Merck & Co.’s backing failed to help patients in a trial for ovarian cancer.
Health Care & Life Sciences
Articles
Health IT firm hc1.com to add up to 175 Boone County jobs
The company said it will invest $2.5 million to lease and renovate an additional 9,466 square feet to expand its current 16,626-square-foot headquarters at Northwest Technology Park.
Indiana signups lag for federal health care law
Data from the U.S. Department of Health and Human Services show that a total of nearly 230,000 Indiana residents were eligible to enroll in a marketplace plan, but only about 132,000 had done so by the March 31 deadline.
IU plots $200M life sciences hub in former Wishard Hospital
The envisioned 26-acre, $200-million-or-more complex would bridge IU’s School of Medicine with the city’s life sciences firms, including those at the nascent 16 Tech, a business park.
St. Vincent and Community to dissolve partnership
The Accountable Care Consortium was envisioned as a vehicle through which the hospitals would eventually funnel all of their roughly $2.5 billion in annual contracts with health insurers and employers.
Enough blame to go around
A new report from the Commonwealth Fund provides plenty to criticize everyone involved in health care in Indiana: It shows health care costs run higher in Indiana than the rest of the country while patients’ health and the quality of health care providers in some key areas are worse.
Drug prices surge as generics, niche treatments eat profit
Since 2007, the cost of brand-name medicines has jumped, with prices doubling for dozens of established drugs that target everything from multiple sclerosis to cancer, blood pressure and even erections, according to an analysis conducted for Bloomberg News.
CEOs launch childhood obesity initiative
Jump IN for Healthy Kids has a budget of $1.5 million and hopes to identify and extend successful efforts to improve diet, activity and healthy choices among children and their families.
WellPoint shares rise after better-than-expected quarter
The Indianapolis-based health insurer increased its profit forecast after Obamacare enrollments boosted quarterly results.
What health care really needs is a full-meal deal
Until doctors and hospitals make a whole lot more headway—or, perhaps, more accurately, are allowed to make more headway—in offering package deals, it’s hard to see major progress on containing out-of-control health care costs.
Roche battles payment cuts while growing diagnostics business
New tests have helped Roche Diagnostics grow its North American revenue, excluding its troubled diabetes care business, 23 percent over the past five years. But the money for diagnostic tests continues to go down in key areas, noted CFO Wayne Burris.
Lilly trade-secret defendants released to home detention
The court noted that after the government filed a second indictment March 12, the trade-secret theft claims against Guoqing Cao and Shuyu Li were changed to wire fraud, and aiding and abetting and conspiracy to commit wire fraud.
CNO takes big earnings hit to dispose of old business
Excluding the cost of finally shedding a block of business from predecessor Conseco Inc., CNO's operations were on the upswing in the first quarter.
Indiana lawmakers struggle with ethics system
Eric Turner, the first lawmaker to be investigated by the House Ethics Committee in close to two decades, is under review for his private lobbying against a proposed ban on the construction of new nursing homes.
Think Obamacare will help hospitals? Think again
The typical hospital around the country will see its profits wiped out entirely by the changes coming from health reform and the aging of the population. But in Indianapolis, the hits will be cushioned by this region's fatter commercial reimbursements.
Novartis deal caps turnaround for Elanco
Next year, after Lilly completes its $5.4 billion acquisition of Novartis Animal Health, Elanco will contribute 17 percent of revenue—or one out of every six dollars flowing into Lilly’s coffers.
Hospitals rethinking a la carte pricing
Indianapolis hospitals have begun to offer joint replacement surgeries to employers and insurers using “bundled prices.” That means, instead of billing piecemeal for each individual service and supply, the hospitals wrap everything needed from just before to just after surgery into a package deal.
Zimmer shares hit 13-year high on Biomet deal
The deal will help Zimmer, a maker of artificial hips and knees, take on Johnson & Johnson, the No. 1 manufacturer in the now-growing $45 billion market.
Zimmer buying Biomet in $13.3B deal between Hoosier firms
Orthopedic device maker Zimmer Holdings Inc. is buying privately-held competitor Biomet Inc. in a cash-and-stock deal between the Warsaw-based companies valued at about $13.35 billion.
Lilly’s quarterly profit meets analyst expectations
The drugmaker, which is weathering patent expirations, saw sales fall more slowly than expected for its antidepressant Cymbalta.